<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Koelsche C</submitter><funding>Deutsche Krebshilfe</funding><pagination>9</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5418758</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>7</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Histone 3.3 (H3.3) hotspot mutations in bone tumors occur in the vast majority of giant cell tumors of bone (GCTBs; 96%), chondroblastomas (95%) and in a few cases of osteosarcomas. However, clinical presentation, histopathological features, and additional molecular characteristics of H3.3 mutant osteosarcomas are largely unknown.&lt;h4>Methods&lt;/h4>In this multicentre, retrospective study, a total of 106 conventional high-grade osteosarcomas, across all age groups were re-examined for hotspot mutations in the H3.3 coding genes &lt;i>H3F3A&lt;/i> and &lt;i>H3F3B&lt;/i>. H3.3 mutant osteosarcomas were re-evaluated in a multidisciplinary manner and analyzed for genome-wide DNA-methylation patterns and DNA copy number aberrations alongside H3.3 wild-type osteosarcomas and &lt;i>H3F3A&lt;/i> G34W</pubmed_abstract><journal>Clinical sarcoma research</journal><pubmed_title>Histone 3.3 hotspot mutations in conventional osteosarcomas: a comprehensive clinical and molecular characterization of six H3F3A mutated cases.</pubmed_title><pmcid>PMC5418758</pmcid><funding_grant_id>70112499</funding_grant_id><pubmed_authors>Renker EK</pubmed_authors><pubmed_authors>Plass C</pubmed_authors><pubmed_authors>Tharun L</pubmed_authors><pubmed_authors>Petersen I</pubmed_authors><pubmed_authors>von Deimling A</pubmed_authors><pubmed_authors>Roth E</pubmed_authors><pubmed_authors>Schreuder HWB</pubmed_authors><pubmed_authors>Weber MA</pubmed_authors><pubmed_authors>Buttner R</pubmed_authors><pubmed_authors>Jones DTW</pubmed_authors><pubmed_authors>Capper D</pubmed_authors><pubmed_authors>Pfister SM</pubmed_authors><pubmed_authors>Mechtersheimer G</pubmed_authors><pubmed_authors>Sturm D</pubmed_authors><pubmed_authors>Schrimpf D</pubmed_authors><pubmed_authors>Kulozik AE</pubmed_authors><pubmed_authors>Koelsche C</pubmed_authors><pubmed_authors>Sahm F</pubmed_authors><pubmed_authors>Schirmacher P</pubmed_authors><pubmed_authors>Bewerunge-Hudler M</pubmed_authors><pubmed_authors>Baude A</pubmed_authors><pubmed_authors>Flucke U</pubmed_authors><pubmed_authors>Sill M</pubmed_authors><pubmed_authors>Hartmann W</pubmed_authors></additional><is_claimable>false</is_claimable><name>Histone 3.3 hotspot mutations in conventional osteosarcomas: a comprehensive clinical and molecular characterization of six H3F3A mutated cases.</name><description>&lt;h4>Background&lt;/h4>Histone 3.3 (H3.3) hotspot mutations in bone tumors occur in the vast majority of giant cell tumors of bone (GCTBs; 96%), chondroblastomas (95%) and in a few cases of osteosarcomas. However, clinical presentation, histopathological features, and additional molecular characteristics of H3.3 mutant osteosarcomas are largely unknown.&lt;h4>Methods&lt;/h4>In this multicentre, retrospective study, a total of 106 conventional high-grade osteosarcomas, across all age groups were re-examined for hotspot mutations in the H3.3 coding genes &lt;i>H3F3A&lt;/i> and &lt;i>H3F3B&lt;/i>. H3.3 mutant osteosarcomas were re-evaluated in a multidisciplinary manner and analyzed for genome-wide DNA-methylation patterns and DNA copy number aberrations alongside H3.3 wild-type osteosarcomas and &lt;i>H3F3A&lt;/i> G34W</description><dates><release>2017-01-01T00:00:00Z</release><publication>2017</publication><modification>2025-05-31T22:53:49.916Z</modification><creation>2025-05-31T22:53:49.916Z</creation></dates><accession>S-EPMC5418758</accession><cross_references><pubmed>28484590</pubmed><doi>10.1186/s13569-017-0075-5</doi></cross_references></HashMap>